Product Liability and Mass Torts

Quantifying Medicare Section 111 Costs

NERA's statistical and epidemiological analysis can help companies comply with the new Medicare reporting standards under Section 111 of the Medicare, Medicaid, and SCHIP Extension Act of 2007 (MMSEA). More specifically, we can estimate the portion of aggregate indemnity payments that are paid to claimants who are also eligible for Medicare reimbursement, and the likely amounts of this Medicare reimbursement. Such an analysis incorporates disease progression and mortality. The analysis can be done for payments that have already occurred, as well as for projected future payments. The results of this modeling efforts can allow companies to set aside appropriate reserves.